GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • Online Resource  (3)
  • Springer Science and Business Media LLC  (3)
  • van Leeuwen, Pim J.  (3)
  • 1
    In: EJNMMI Research, Springer Science and Business Media LLC, Vol. 12, No. 1 ( 2022-12)
    Abstract: High urinary activity in urinary bladder and ureters may hamper interpretation of prostate cancer and regional nodal metastases in prostate-specific membrane antigen (PSMA) PET/CT. The goal of this study was to assess effects of furosemide and choice of tracer on urinary activity in the bladder and ureters, as well as on occurrence of peri-bladder artefacts in PET/CT. Methods Four cohorts with a total of 202 men staged with PSMA PET/CT for prostate cancer received either 68 Ga-PSMA-11 as tracer, with (cohort G+) or without 10mg intravenous furosemide (G−) concurrent with tracer, or 18 F-DCFPyL with (F+) or without furosemide (F−). SUVmax of bladder and ureters, presence, type, and severity of peri-bladder artefacts were compared between cohorts. The influence of furosemide and choice of tracer was determined while taking differences in biodistribution time into account. Results Median SUVmax bladder was 43,5; 14,8; 61,7 and 22,8 in cohorts G−, G+, F− and F+, respectively, resulting in significant overall ( p  〈  0.001) and between cohort differences ( p adjusted 〈  0.001 to 0.003) except between G− and F+. Median SUVmax ureter was 6.4; 4.5; 8.1 and 6.0 in cohorts G−, G+, F− and F+, respectively, resulting in significant overall ( p  〈  0.001) and between cohort differences for G+ : F− and F− : F+ ( p  〈  0.001, respectively, 0.019). Significant effects of furosemide and choice of tracer on SUVmax bladder ( p  〈  0.001 resp. p  = 0.001) and of furosemide on SUVmax ureter ( p  〈  0.001) were found, whereas differences in biodistribution time had not impacted these results significantly. Peri-bladder artefacts were present in 42/202 (21%) patients and were significantly more frequent in the F− cohort, respectively, less frequent in the G+ cohort ( p  = 0.001 resp. p  〈  0.001). Peri-bladder artefacts had a direct positive correlation with SUVmax bladder ( p  = 0.033). Conclusions Increased urinary activity and higher incidence of peri-bladder artefacts were found in 18 F-DCFPyL compared to 68 Ga-PSMA-11 PET/CT. Effective reduction of urinary activity may be reached through forced diuresis using 10mg intravenous furosemide, which is especially advantageous in 18 F-DCFPyL PET/CT.
    Type of Medium: Online Resource
    ISSN: 2191-219X
    Language: English
    Publisher: Springer Science and Business Media LLC
    Publication Date: 2022
    detail.hit.zdb_id: 2619892-7
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    In: Tijdschrift voor Urologie, Springer Science and Business Media LLC, Vol. 11, No. 1 ( 2021-01), p. 2-10
    Abstract: We created a model predicting the probability to detect prostate cancer recurrence outside the prostatic fossa in men with biochemical recurrence (BCR) after radical prostatectomy (RP). 419 patients with BCR (prostate specific antigen [PSA] 〈  2.0 ng/ml) after RP without hormone therapy underwent a 68 Ga-Prostate Specific Membrane Antigen (PSMA) Positron Emission Tomography/Computer Tomograpy (PET/CT)-scan. Predictors for the detection of prostate cancer recurrence outside the prostatic fossa were identified using multivariable logistic regression analysis. At a median PSA of 0,40 ng/ml (interquartile range 0,30–0,70), PSMA PET/CT detected prostate cancer recurrence outside the prostatic fossa in 174 (42%) patients. Significant predictors for the detection of prostate cancer recurrence outside the prostatic fossa were PSA value at time of scanning and RP specimen characteristics Gleason-score, lymph node status and surgical margin status. PSA value at time of scanning and RP specimen characteristics, Gleason-score, lymph node status and surgical margin status are all important predictors for the probability to detect prostate cancer recurrence outside the prostatic fossa. The dashboard ( https://psma.prostatecancer-riskcalculator.com/ ) can be used to determine the clinical most optimal moment to perform a PSMA PET/CT scan.
    Type of Medium: Online Resource
    ISSN: 2211-3037 , 2211-4718
    Language: Dutch
    Publisher: Springer Science and Business Media LLC
    Publication Date: 2021
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    In: BMC Cancer, Springer Science and Business Media LLC, Vol. 20, No. 1 ( 2020-12)
    Abstract: To evaluate the impact of Gallium-68 [ 68 Ga] labeled prostate specific membrane antigen (PSMA) positron emission tomography (PET)/X-ray computed tomography (CT) compared with conventional imaging on staging and clinical management of men evaluated for primary prostate cancer (PCa). Methods Men with newly diagnosed biopsy-proven PCa who had been staged with a conventional staging protocol including bone scintigraphy (BS) and additionally underwent [ 68 Ga]PSMA PET/CT, were evaluated retrospectively. Imaging findings from BS, magnetic resonance imaging (MRI) and/or CT were categorized regarding locoregional nodal (N) and distant metastasis (M) status as negative, positive or equivocal before and after addition of the information of PET/CT. Also, the imaging-based level of confidence (LoC) in correct assessment of N and M status was scored. Impact of PET/CT on clinical management was evaluated by the percentage of treatment category changes after PET/CT as determined in the multidisciplinary tumour board. Results Sixty-four men with intermediate and high-risk PCa were evaluated. With additional information of PET/CT, N status was upstaged in 23%, and downstaged in 9%. M status was upstaged in 13%, and downstaged in 23%. A net increase in LoC of 20% was noted, mainly regarding M status. Treatment category changed from palliative to curative in 9%, and from curative to palliative in 3%. An undecided treatment plan changed to curative in 14%, as well as to palliative in another 9%. In total, a 36% treatment category change was noted. High negative predictive value of PET/CT for M status was indicated by 27 patients that underwent robot-assisted radical prostatectomy and reached postoperative biochemical disease-free status or had a likely other site of disease recurrence. Conclusions PSMA PET/CT can cause considerable changes in N and M staging, as well as in management compared to conventional staging. Findings of this study support the replacement of BS and CT by PSMA PET/CT in staging primary PCa.
    Type of Medium: Online Resource
    ISSN: 1471-2407
    Language: English
    Publisher: Springer Science and Business Media LLC
    Publication Date: 2020
    detail.hit.zdb_id: 2041352-X
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...